| Not Yet Recruiting | Clinical Trial to Investigate the Efficacy and Safety of Ondansetron (Danset - Adwia) Versus Placebo Plus the Gastroenteritis | Phase 3 | 2025-06-01 |
| Recruiting | Study of Bisoprolol (Nerkardou - Nerhadou International) 5 and 10 mg Oral Dissolvable Film (ODF) Treatment in Essential Hypertension | Phase 4 | 2024-08-08 |
| Completed | Bioequivalence Study of of Metformin HCl From Gleptomet 50/1000 mg F.C.Tablets (EVA Pharma, Egypt) and Janumet Healthy | Phase 1 | 2022-11-29 |
| Completed | Bioequivalence Study of Modafinil From Bravamax 200 mg Scored Tablets (Chemipharm Pharmaceutical Industries, E Healthy | Phase 1 | 2022-11-15 |
| Completed | Bioequivalence Study of Aripiprazole From Apipe 10 mg Orally Disintegrating Tablets (Man. by: P&C Labs (Pellet Healthy | Phase 1 | 2022-10-10 |
| Completed | Bioequivalence Study of Nirmatrelvir & Ritonavir From Copaxid 150 +100 mg Tablets (Eva Pharma, Egypt) Versus P Healthy | Phase 1 | 2022-08-21 |
| Completed | Bioequivalence Study of Solifenacin Succinate & Mirabegron From Mirfenacin MR 5/50 mg Extended Release Tablets Healthy | Phase 1 | 2022-05-30 |
| Completed | Bioequivalence Study of Baricitinib From Barcimiant 4 mg Film Coated Tablets (Horus Pharma, Egypt) and Olumian Healthy | Phase 1 | 2021-05-05 |
| Completed | Bioequivalence Study of Esomeprazole From Stomopral 40 mg Capsules Contain Enteric Coated Pellets (Future Phar Healthy | Phase 1 | 2021-03-18 |
| Completed | Bioequivalence Study of Ivermectin From Revemact 6 mg Tablets (Man. by EVA Pharma for Horus for Pharmaceutical Healthy | Phase 1 | 2021-01-28 |
| Completed | Bioequivalence Study of Vonoprazan From Topoprazan 20 mg Tablets (Hikma Pharma, Egypt) Versus Takecab 20 mg Ta Healthy | Phase 1 | 2021-01-19 |
| Completed | Bioequivalence Study of Budesonide From Ekmasonid 9 mg Extended Release FCT (Hikma Pharma, Egypt) Versus Uceri Healthy | Phase 1 | 2020-09-17 |
| Completed | Bioequivalence Study of Favipiravir From Flupirava 200 mg Tablet (European Egyptian Pharmaceutical Industries Healthy | Phase 1 | 2020-08-13 |
| Completed | Bioequivalence Study of Fingolimod From Sphingomod 0.5 mg Hard Gelatin Capsules (Hikma Pharma, Egypt) Versus G Healthy | Phase 1 | 2020-08-10 |
| Completed | Bioequivalence Study of Mirabegron From Bladogra 25 mg Extended Release Tablets (Multi-Apex for Pharmaceutical Healthy | Phase 1 | 2020-01-20 |
| Completed | Bioequivalence Study of Empagliflozin & Metformin HCL From Empagliform 12.5/1000 mg F.C.T (Hikma Pharma, Egypt Healthy | Phase 1 | 2019-03-26 |
| Completed | Bioequivalence Study of Flibanserin From AphroFemine 100 mg F.C.T (Bio Med for Pharmaceuticals Industries (BIO Healthy | Phase 1 | 2018-12-12 |
| Completed | A Bioequivalence Study of Glibenclamide From Glibesyn 5 mg Tablets (Medochemie LTD Cyprus) and Daonil 5 mg Tab Healthy | Phase 1 | 2018-06-30 |
| Completed | A Study of Sofosbuvir and Ledipasvir From Soviredia 90/400 mg Tablets (Minapharm, Egypt) Versus Harvoni 90/400 Healthy | Phase 1 | 2017-04-05 |
| Completed | A Study of Sofosbuvir and Ledipasvir From Magicbuvir Plus 90/400 mg Tablets (Magic Pharma, Egypt) Versus Harvo Healthy | Phase 1 | 2016-11-01 |
| Completed | A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Healthy | Phase 1 | 2016-10-01 |
| Completed | A Bio-equivalence Study of Sofosbuvir From Magicbuvir 400 mg Film Coated Tablets ( Magic Pharma, Egypt) Versus Healthy | Phase 1 | 2016-05-01 |
| Completed | Bioequivalence Study of Daclatasvir From Prodactariv 60 mg Film Coated Tablets (International Drug Agency for Healthy | Phase 1 | 2016-04-01 |
| Completed | Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets ( Healthy | Phase 1 | 2016-02-01 |
| Completed | Bioequivalence Study of Daclatasvir From Daclatasvir Zeta 60 mg Film Coated Tablets (Zeta Pharm Pharmaceutical Healthy | Phase 1 | 2016-02-01 |
| Completed | Bioequivalence Study of Daclatasvir From Daktavira 60 mg Film Coated Tablets ( European Egyptian Pharmaceutica Healthy | Phase 1 | 2015-12-01 |
| Completed | A Bio-equivalence Study of Sofosbuvir From Elbanovir 400 mg Film Coated Tablets ( Multi-Apex Pharma, Egypt) & Healthy | Phase 1 | 2015-08-01 |
| Completed | A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilea Healthy | Phase 1 | 2015-02-01 |
| Completed | Bioequivalence Study of Rivaroxaban From Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Industries, Egypt Healthy | Phase 1 | 2015-02-01 |
| Completed | A Bioequivalence Study of Montelukast From Asmakast 10mg Tabs (Sandoz, Egypt) & Singulair 10mg Tabs (Merck) Healthy | Phase 1 | 2014-08-01 |
| Completed | Bioequivalence Study of Montelukast From Asmakast 5mg Chewable Tab.(Sandoz, Egypt) & Singulair 5mg Chewable Ta Healthy | Phase 1 | 2014-04-01 |
| Completed | A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma) Healthy | Phase 1 | 2014-03-01 |
| Completed | A Bioequivalence Study of Rabeprazole From Idiazole 20mg DR Tabs (GSK, Egypt) and PARIET 20 mg DR Tabs (JANSSE Healthy | Phase 1 | 2014-03-01 |
| Completed | Bioequivalence Study of Vildagliptin From Gliptus 50 mg Tablet (EVA Pharma, Egypt) and Galvus 50 mg Tablet (NO Healthy | Phase 1 | 2014-02-01 |
| Completed | Biosimilarity Study of IM Injection of Human Chorionic Gonadotrophin After Parenteral Administration of Treatm Infertility, Female | Phase 4 | 2013-08-30 |
| Completed | A Bioequivalence Study of Oseltamivir From Oseltamivir 75 mg Caps (Pharmacare PLC, Palestine) and Tamiflu® 75 Healthy | Phase 1 | 2013-03-01 |
| Completed | A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 m Healthy | Phase 1 | 2013-02-01 |
| Completed | A Bioequivalence Study of Amlodipine / Valsartan From Amlodipine/Valsartan 10/160 Tablets (Pharmacare, Palesti Healthy | Phase 1 | 2011-03-01 |